Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.

Nishio S, Hatano M, Nagata M, Horie S, Koike T, Tokuhisa T, Mochizuki T.

J Clin Invest. 2005 Apr;115(4):910-8. Epub 2005 Mar 3.

2.

Molecular basis of autosomal dominant polycystic kidney disease.

Al-Bhalal L, Akhtar M.

Adv Anat Pathol. 2005 May;12(3):126-33. Review.

PMID:
15900113
3.

Autosomal dominant polycystic kidney disease: clues to pathogenesis.

Harris PC.

Hum Mol Genet. 1999;8(10):1861-6. Review.

PMID:
10469838
5.

Recent advances in the understanding of polycystic kidney disease.

Bacallao RL, Carone FA.

Curr Opin Nephrol Hypertens. 1997 Jul;6(4):377-83. Review.

PMID:
9263688
6.

Pathogenesis of autosomal dominant polycystic kidney disease: role of apoptosis.

Zhou XJ, Kukes G.

Diagn Mol Pathol. 1998 Apr;7(2):65-8. Review.

PMID:
9785003
7.

New developments in the field of cystic kidney diseases.

Witzgall R.

Curr Mol Med. 2005 Aug;5(5):455-65. Review.

PMID:
16101475
8.

Epithelial cell polarity and disease.

Wilson PD.

Am J Physiol. 1997 Apr;272(4 Pt 2):F434-42. Review.

PMID:
9140043
9.

Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.

Cai Y, Tang Z.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Feb;35(2):93-9. doi: 10.3969/j.issn.1672-7347.2010.02.001. Review.

10.

[Pathogenesis of cystic kidney diseases].

Walz G.

Verh Dtsch Ges Pathol. 2002;86:138-44. Review. German.

PMID:
12647363
11.

Molecular basis of autosomal-dominant polycystic kidney disease.

Gallagher AR, Hidaka S, Gretz N, Witzgall R.

Cell Mol Life Sci. 2002 Apr;59(4):682-93. Review.

PMID:
12022474
12.

Recent advances in the cell biology of polycystic kidney disease.

Smyth BJ, Snyder RW, Balkovetz DF, Lipschutz JH.

Int Rev Cytol. 2003;231:51-89. Review.

PMID:
14713003
13.
14.

Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models.

Bichet D, Peters D, Patel AJ, Delmas P, Honoré E.

Trends Cardiovasc Med. 2006 Nov;16(8):292-8. Review.

PMID:
17055386
15.

Epithelial transport in polycystic kidney disease.

Sullivan LP, Wallace DP, Grantham JJ.

Physiol Rev. 1998 Oct;78(4):1165-91. Review.

16.

ADPKD: molecular characterization and quest for treatment.

Horie S.

Clin Exp Nephrol. 2005 Dec;9(4):282-91. Review.

PMID:
16362154
17.

Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.

Sutters M, Germino GG.

J Lab Clin Med. 2003 Feb;141(2):91-101. Review.

PMID:
12577044
18.

[Variable progression of autosomal dominant polycystic kidney disease: genetic and molecular counterparts].

Devuyst O.

Nephrol Ther. 2006 Jan;2 Suppl 2:S104-8. Review. French.

PMID:
17373208
19.

The pathogenesis of polycystic kidney disease.

Carone FA, Bacallao R, Kanwar YS.

Histol Histopathol. 1995 Jan;10(1):213-21. Review.

PMID:
7756739
20.

Supplemental Content

Support Center